MX2017000955A - Preparacion de una forma solida de dimeglumina de gadobenato. - Google Patents

Preparacion de una forma solida de dimeglumina de gadobenato.

Info

Publication number
MX2017000955A
MX2017000955A MX2017000955A MX2017000955A MX2017000955A MX 2017000955 A MX2017000955 A MX 2017000955A MX 2017000955 A MX2017000955 A MX 2017000955A MX 2017000955 A MX2017000955 A MX 2017000955A MX 2017000955 A MX2017000955 A MX 2017000955A
Authority
MX
Mexico
Prior art keywords
solid form
gadobenate dimeglumine
preparation
solution
compound
Prior art date
Application number
MX2017000955A
Other languages
English (en)
Inventor
Fretta Roberta
Mazzon Roberta
Lucio Anelli Pier
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Publication of MX2017000955A publication Critical patent/MX2017000955A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38Separation; Purification; Stabilisation; Use of additives
    • C07C227/40Separation; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación de una forma sólida del compuesto de dimeglumina de gadobenato que comprende obtener una solución de tal compuesto en un solvente A adecuado en donde la cantidad por peso del agua opcionalmente presente en la solución es como mucho igual a o menor que la cantidad por peso de la dimeglumina de gadobenato comprendida en la solución y agregar la solución obtenida a un solvente orgánico B, que actúa como un antisolvente apropiado y favoreciendo la formación de una forma sólida de la dimeglumina de gadobenato que se puede colectar por filtración.
MX2017000955A 2014-07-24 2015-07-20 Preparacion de una forma solida de dimeglumina de gadobenato. MX2017000955A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14178283.9A EP2977369A1 (en) 2014-07-24 2014-07-24 Preparation of a solid form of gadobenate dimeglumine
PCT/EP2015/066512 WO2016012386A1 (en) 2014-07-24 2015-07-20 Preparation of a solid form of gadobenate dimeglumine

Publications (1)

Publication Number Publication Date
MX2017000955A true MX2017000955A (es) 2017-05-01

Family

ID=51260603

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000955A MX2017000955A (es) 2014-07-24 2015-07-20 Preparacion de una forma solida de dimeglumina de gadobenato.

Country Status (23)

Country Link
US (2) US10519171B2 (es)
EP (2) EP2977369A1 (es)
JP (1) JP6625605B2 (es)
KR (1) KR102445718B1 (es)
CN (2) CN111233684B (es)
AU (1) AU2015294042B2 (es)
BR (1) BR112016030362A2 (es)
CA (1) CA2950831C (es)
CY (1) CY1122739T1 (es)
DK (1) DK3172186T3 (es)
ES (1) ES2701099T3 (es)
HR (1) HRP20182018T1 (es)
IL (1) IL250248B (es)
LT (1) LT3172186T (es)
MX (1) MX2017000955A (es)
NZ (1) NZ727066A (es)
PL (1) PL3172186T3 (es)
PT (1) PT3172186T (es)
RS (1) RS58085B1 (es)
RU (1) RU2693625C2 (es)
SG (1) SG11201610655WA (es)
SI (1) SI3172186T1 (es)
WO (1) WO2016012386A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114845990A (zh) 2019-12-20 2022-08-02 伯拉考成像股份公司 钙bopta配合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3520066A (en) * 1966-05-26 1970-07-14 Pillsbury Co Spray drying method
IT1213029B (it) 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
ITMI981583A1 (it) * 1998-07-10 2000-01-10 Bracco Spa Processo per la preparazione dell'acido 4 -carbossi-5,8,11-tris (carbossimetil)-1-fenil-2-oxa-5,8,11-triazatridecan-13-oico
EP2327395A1 (en) * 2009-11-23 2011-06-01 Bracco Imaging S.p.A Process for the preparation of gadobenate dimeglumine complex in a solid form
EP2338874A1 (en) * 2009-12-16 2011-06-29 Bracco Imaging S.p.A Process for the preparation of chelated compounds
CN102408348A (zh) * 2011-07-26 2012-04-11 天津市海文普宁科技发展有限公司 一种钆贝葡胺的制备新方法

Also Published As

Publication number Publication date
PT3172186T (pt) 2018-12-12
WO2016012386A1 (en) 2016-01-28
ES2701099T3 (es) 2019-02-20
KR20170039125A (ko) 2017-04-10
RS58085B1 (sr) 2019-02-28
AU2015294042B2 (en) 2019-01-24
BR112016030362A2 (pt) 2018-07-17
US10519171B2 (en) 2019-12-31
US20170190719A1 (en) 2017-07-06
US20200071341A1 (en) 2020-03-05
CY1122739T1 (el) 2020-11-25
US11014942B2 (en) 2021-05-25
SI3172186T1 (sl) 2019-01-31
IL250248A0 (en) 2017-03-30
LT3172186T (lt) 2019-02-11
CN111233684B (zh) 2023-05-26
CN106573875B (zh) 2020-03-27
DK3172186T3 (en) 2019-01-07
JP6625605B2 (ja) 2019-12-25
RU2017105846A (ru) 2018-08-27
CN106573875A (zh) 2017-04-19
NZ727066A (en) 2020-04-24
PL3172186T3 (pl) 2019-02-28
SG11201610655WA (en) 2017-02-27
AU2015294042A1 (en) 2016-12-22
CA2950831A1 (en) 2016-01-28
EP3172186B1 (en) 2018-09-12
CA2950831C (en) 2020-12-29
IL250248B (en) 2019-10-31
KR102445718B1 (ko) 2022-09-21
EP2977369A1 (en) 2016-01-27
EP3172186A1 (en) 2017-05-31
CN111233684A (zh) 2020-06-05
JP2017525682A (ja) 2017-09-07
RU2017105846A3 (es) 2019-02-14
HRP20182018T1 (hr) 2019-02-08
RU2693625C2 (ru) 2019-07-03

Similar Documents

Publication Publication Date Title
MX2021014128A (es) Polimorfos de selinexor.
MX2021014663A (es) Il-23a y tnf-alfa orientados y compuesto y sus usos.
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
WO2014086982A3 (en) Stable metal compounds, their compositions and methods of their use
HRP20220313T1 (hr) Procesi za pripremu spojeva sličnih oksatiazinu
PL3102554T3 (pl) Konwersja 2,3-butanodiolu do butadienu
JO3487B1 (ar) تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به
IN2014MU00455A (es)
MX2016014244A (es) Metodo para secar mezclas de sabores de reaccion.
UA116913C2 (uk) Спосіб отримання ксантогумолу
NZ727066A (en) Preparation of a solid form of gadobenate dimeglumine
EA201591449A1 (ru) Способы получения противораковых композиций
IN2013MU01290A (es)
EA030274B9 (ru) Модифицированная сушкой, активированная кислотой отбеливающая земля, способ ее получения и применение
IN2013MU03508A (es)
MY156402A (en) Hydraulic composition
MX2012014971A (es) Dosis fija de combinacion de sildenafilo y dapoxetina.
TW201613927A (en) Method for preparation of substituted imidazopyridazines
MX2017016998A (es) Emulsion de propofol para administracion parenteral.
GB201522953D0 (en) The additive to improve the utilization rate of soil organic carbon
NZ767083A (en) Polymorphs of selinexor
RU2014129346A (ru) Способ извлечения бензола из бензиновых фракций
CL2014003246A1 (es) Compuestos derivados de 2-fenil-2-fluorosulfonamidas y procedimiento de preparación; útiles como bloques de construcción en síntesis orgánica.
UA105806U (uk) Спосіб отримання 3-аліл-5-r-2-тіогідантоїнів
IL241218B (en) Sandstone obtained as a result of blending brackish sands, in a special context for desert sands, a compound for blending these sands, and a process for blending brackish sands, especially desert sands

Legal Events

Date Code Title Description
FG Grant or registration